Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p/SF3B3 axis

References

• Liu N, Wang L, Yang T, et al. EGF receptor inhibition alleviates hyperuricemic nephropathy. J Am Soc Nephrol. 2015;26(11):2716–2729.
   PubMed Web of Science ®Google Scholar
• Wang JL, Chen CW, Tsai MR, et al. Antifibrotic role of PGC-1alpha-siRNA against TGF-beta1-induced renal interstitial fibrosis. Exp Cell Res. 2018;370(1):160–167.
   PubMed Web of Science ®Google Scholar
• Ji X, Cao J, Zhang L, et al. Kaempferol protects renal fibrosis through activating the BMP-7-Smad1/5 signaling pathway. Biol Pharm Bull. 2020;43(3):533–539.
   PubMed Web of Science ®Google Scholar
• Xiao H, Shen HY, Liu W, et al. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS One. 2013;8(4):e60173.
   PubMed Web of Science ®Google Scholar
• Ruan GP, Xu F, Li ZA, et al. Induced autologous stem cell transplantation for treatment of rabbit renal interstitial fibrosis. PLoS One. 2013;8(12):e83507.
   PubMed Web of Science ®Google Scholar
• Hyndman KA. Histone deacetylases in kidney physiology and acute kidney injury. Semin Nephrol. 2020;40(2):138–147.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zou J, Tolbert E, et al. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis. FASEB J. 2020;34(6):7295–7310.
   PubMed Web of Science ®Google Scholar
• Yang M, Chen G, Zhang X, et al. Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model. Pharmacol Res. 2019;142:192–204.
   PubMed Web of Science ®Google Scholar
• Lin W, Zhang Q, Liu L, et al. Klotho restoration via acetylation of peroxisome proliferation-activated receptor gamma reduces the progression of chronic kidney disease. Kidney Int. 2017;92(3):669–679.
   PubMed Web of Science ®Google Scholar
• Swierczynski S, Klieser E, Illig R, et al. Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases. Expert Opin Biol Ther. 2015;15(5):651–664.
   PubMed Web of Science ®Google Scholar
• Muendlein A, Geiger K, Leiherer A, et al. Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients. Am J Physiol Renal Physiol. 2020;318(2):F315–F321.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhou ZQ, Ren YQ, et al. Effects of long non-coding RNA LINC00667 on renal tubular epithelial cell proliferation, apoptosis and renal fibrosis via the miR-19b-3p/LINC00667/CTGF signaling pathway in chronic renal failure. Cell Signal. 2019;54:102–114.
   PubMed Web of Science ®Google Scholar
• Xiao B, Wang LN, Li W, et al. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis. Cell Death Dis. 2018;9(5):533.
   PubMedGoogle Scholar
• Liao LN, Chen CC, Wu FY, et al. Identified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese population. BMC Genet. 2014;15:113.
   PubMed Web of Science ®Google Scholar
• Chen K, Xiao H, Zeng J, et al. Alternative splicing of EZH2 pre-mRNA by SF3B3 contributes to the tumorigenic potential of renal cancer. Clin Cancer Res. 2017;23(13):3428–3441.
   PubMed Web of Science ®Google Scholar
• Ding H, Xu Y, Jiang N. Upregulation of miR-101a suppresses chronic renal fibrosis by regulating KDM3A via blockade of the YAP-TGF-beta-Smad signaling pathway. Mol Ther Nucleic Acids. 2020;19:1276–1289.
   PubMedGoogle Scholar
• Chen Y, Li C, Duan S, et al. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother. 2019;118:109195.
   PubMed Web of Science ®Google Scholar
• Li L, Chen Y, Jiao D, et al. Protective effect of astaxanthin on ochratoxin A-induced kidney injury to mice by regulating oxidative stress-related NRF2/KEAP1 pathway. Molecules. 2020;25:6.
   Web of Science ®Google Scholar
• Xie Y, Lan F, Zhao J, et al. Hirudin improves renal interstitial fibrosis by reducing renal tubule injury and inflammation in unilateral ureteral obstruction (UUO) mice. Int Immunopharmacol. 2020;81:106249.
   PubMed Web of Science ®Google Scholar
• Zhou H, Qiu ZZ, Yu ZH, et al. Paeonol reverses promoting effect of the HOTAIR/miR-124/Notch1 axis on renal interstitial fibrosis in a rat model. J Cell Physiol. 2019;234(8):14351–14363.
   PubMed Web of Science ®Google Scholar
• Chen L, Xiang E, Li C, et al. Umbilical cord-derived mesenchymal stem cells ameliorate nephrocyte injury and proteinuria in a diabetic nephropathy rat model. J Diabetes Res. 2020;2020:8035853.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Ji C, Zhang J, Zhu Y, et al. Exosomes derived from hucMSC attenuate renal fibrosis through CK1delta/beta-TRCP-mediated YAP degradation. Cell Death Dis. 2020;11(5):327.
   PubMed Web of Science ®Google Scholar
• Wang Y, Frank DB, Morley MP, et al. HDAC3-dependent epigenetic pathway controls lung alveolar epithelial cell remodeling and spreading via miR-17-92 and TGF-beta signaling regulation. Dev Cell. 2016;36(3):303–315.
   PubMed Web of Science ®Google Scholar
• Pan G, Mao A, Liu J, et al. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif. 2020;53(2):e12720.
   PubMed Web of Science ®Google Scholar
• Li Y, Gao M, Xu LN, et al. MicroRNA-142-3p attenuates hepatic ischemia/reperfusion injury via targeting of myristoylated alanine-rich C-kinase substrate. Pharmacol Res. 2020;156:104783.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao S, Zhu Y. Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2. FASEB J. 2020;34(2):2703–2714.
   PubMed Web of Science ®Google Scholar
• Shan Q, Zheng G, Zhu A, et al. Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus. Toxicol Appl Pharmacol. 2016;306:134–143.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Maruko I, Koizumi H, et al. Quantification of choroidal vasculature by high-quality structure en face swept-source optical coherence tomography images in eyes with central serous chorioretinopathy. Retina. 2020;40(3):529–536.
   PubMed Web of Science ®Google Scholar
• Yamaguchi I, Tchao BN, Burger ML, et al. Vascular endothelial cadherin modulates renal interstitial fibrosis. Nephron Exp Nephrol. 2012;120(1):e20–31.
   PubMedGoogle Scholar
• Tung CW, Hsu YC, Cai CJ, et al. Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway. Sci Rep. 2017;7(1):14495.
   PubMedGoogle Scholar
• Liu Y, Wang Z, Wang J, et al. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-beta and vascular endothelial growth factor signalling. Liver Int. 2013;33(4):504–515.
   PubMed Web of Science ®Google Scholar
• Hyndman KA, Kasztan M, Mendoza LD, et al. Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation. Am J Physiol Renal Physiol. 2019;316(5):F875–F888.
   PubMed Web of Science ®Google Scholar
• Van Beneden K, Geers C, Pauwels M, et al. Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. Toxicol Appl Pharmacol. 2013;271(2):276–284.
   PubMed Web of Science ®Google Scholar
• Brandon-Warner E, Benbow JH, Swet JH, et al. Adeno-associated virus serotype 2 vector-mediated reintroduction of microRNA-19b attenuates hepatic fibrosis. Hum Gene Ther. 2018;29(6):674–686.
   PubMed Web of Science ®Google Scholar
• Ge S, Xie J, Liu F, et al. MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol. J Cell Biochem. 2015;116(11):2455–2464.
   PubMed Web of Science ®Google Scholar
• Gokmen-Polar Y, Neelamraju Y, Goswami CP, et al. Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer. Mod Pathol. 2015;28(5):677–685.
   PubMed Web of Science ®Google Scholar